STOCK TITAN

[SCHEDULE 13G] 180 Life Sciences Corp. Warrant SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Steadfast Capital Management LP and affiliated entities reported beneficial ownership of 11,320,754 shares of 180 Life Sciences Corp. common stock, equal to 7.3% of 154,032,084 shares outstanding. The filing names the Investment Manager, American Steadfast, Steadfast International Master Fund and Robert S. Pitts Jr.; Mr. Pitts is the controlling principal of the Investment Manager. The Investment Manager has shared voting and dispositive power over the shares held by the two funds. The statement certifies the holdings are not held to change or influence control of the issuer.

Steadfast Capital Management LP e società affiliate hanno dichiarato la titolarità effettiva di 11.320.754 azioni ordinarie di 180 Life Sciences Corp., pari al 7,3% di 154.032.084 azioni in circolazione. Il deposito indica come parti interessate l'Investment Manager, American Steadfast, lo Steadfast International Master Fund e Robert S. Pitts Jr.; il sig. Pitts è il socio di controllo dell'Investment Manager. L'Investment Manager esercita poteri congiunti di voto e di disposizione sulle azioni detenute dai due fondi. La dichiarazione certifica che le partecipazioni non sono detenute al fine di modificare o influenzare il controllo dell'emittente.

Steadfast Capital Management LP y entidades afiliadas informaron la propiedad beneficiaria de 11,320,754 acciones ordinarias de 180 Life Sciences Corp., equivalentes al 7,3% de 154,032,084 acciones en circulación. La presentación nombra al Investment Manager, American Steadfast, Steadfast International Master Fund y a Robert S. Pitts Jr.; el Sr. Pitts es el principal controlador del Investment Manager. El Investment Manager tiene poderes compartidos de voto y disposición sobre las acciones que poseen los dos fondos. La declaración certifica que las participaciones no se mantienen con la intención de cambiar o influir en el control del emisor.

Steadfast Capital Management LP 및 계열사는 180 Life Sciences Corp. 보통주 11,320,754주(총 발행주식 154,032,084주의 7.3%)에 대한 실질적 소유권을 신고했습니다. 제출서에는 투자운용사(Investment Manager), American Steadfast, Steadfast International Master Fund 및 Robert S. Pitts Jr.가 기재되어 있으며, Pitts 씨가 해당 투자운용사의 지배 주체입니다. 투자운용사는 두 펀드가 보유한 주식에 대해 공동으로 의결권 및 처분권을 보유하고 있습니다. 성명에서는 보유 목적이 발행사의 지배권 변경 또는 영향력을 행사하기 위한 것이 아님을 인증합니다.

Steadfast Capital Management LP et des entités affiliées ont déclaré une détention bénéficiaire de 11 320 754 actions ordinaires de 180 Life Sciences Corp., soit 7,3 % de 154 032 084 actions en circulation. Le dépôt nomme le gestionnaire d'investissement (Investment Manager), American Steadfast, le Steadfast International Master Fund et Robert S. Pitts Jr. ; M. Pitts est le principal dirigeant contrôlant du gestionnaire. Le gestionnaire d'investissement détient des pouvoirs de vote et de disposition partagés sur les actions détenues par les deux fonds. La déclaration certifie que ces participations ne sont pas détenues dans le but de modifier ou d'influencer le contrôle de l'émetteur.

Steadfast Capital Management LP und verbundene Unternehmen meldeten wirtschaftliches Eigentum an 11.320.754 Stück Stammaktien von 180 Life Sciences Corp., entsprechend 7,3% von 154.032.084 ausstehenden Aktien. Die Einreichung nennt den Investment Manager, American Steadfast, den Steadfast International Master Fund und Robert S. Pitts Jr.; Herr Pitts ist der kontrollierende Hauptgesellschafter des Investment Managers. Der Investment Manager verfügt über geteilte Stimm- und Verfügungsbefugnisse bezüglich der von den beiden Fonds gehaltenen Aktien. Die Erklärung bestätigt, dass die Beteiligungen nicht gehalten werden, um die Kontrolle des Emittenten zu ändern oder zu beeinflussen.

Positive
  • Reported beneficial ownership of 11,320,754 shares, representing 7.3% of outstanding common stock
Negative
  • None.

Insights

TL;DR: A meaningful passive stake disclosed—material but non-control, signaling investor interest without activist intent.

The Reporting Persons disclose an aggregate position of 11,320,754 shares, representing 7.3% of outstanding common stock based on the issuer's reported 154,032,084 shares outstanding. Filing on Schedule 13G and the included certification indicate this is a passive disclosure rather than an active control pursuit. For investors, this signals sizeable institutional interest that could affect liquidity and shareholding dynamics but does not indicate imminent governance changes.

TL;DR: Grouped ownership under a single manager with shared voting power, but the filing affirms no intent to influence control.

The filing identifies a clear reporting group structure: an investment manager, two funds and an individual controlling principal who holds shared voting and dispositive power over the disclosed shares. The certification in Item 10 aligns the filing with passive investor status under Schedule 13G rules. From a governance perspective, the arrangement creates a concentrated but disclosed block that management and other shareholders should monitor for voting alignment, though no change-of-control objective is stated.

Steadfast Capital Management LP e società affiliate hanno dichiarato la titolarità effettiva di 11.320.754 azioni ordinarie di 180 Life Sciences Corp., pari al 7,3% di 154.032.084 azioni in circolazione. Il deposito indica come parti interessate l'Investment Manager, American Steadfast, lo Steadfast International Master Fund e Robert S. Pitts Jr.; il sig. Pitts è il socio di controllo dell'Investment Manager. L'Investment Manager esercita poteri congiunti di voto e di disposizione sulle azioni detenute dai due fondi. La dichiarazione certifica che le partecipazioni non sono detenute al fine di modificare o influenzare il controllo dell'emittente.

Steadfast Capital Management LP y entidades afiliadas informaron la propiedad beneficiaria de 11,320,754 acciones ordinarias de 180 Life Sciences Corp., equivalentes al 7,3% de 154,032,084 acciones en circulación. La presentación nombra al Investment Manager, American Steadfast, Steadfast International Master Fund y a Robert S. Pitts Jr.; el Sr. Pitts es el principal controlador del Investment Manager. El Investment Manager tiene poderes compartidos de voto y disposición sobre las acciones que poseen los dos fondos. La declaración certifica que las participaciones no se mantienen con la intención de cambiar o influir en el control del emisor.

Steadfast Capital Management LP 및 계열사는 180 Life Sciences Corp. 보통주 11,320,754주(총 발행주식 154,032,084주의 7.3%)에 대한 실질적 소유권을 신고했습니다. 제출서에는 투자운용사(Investment Manager), American Steadfast, Steadfast International Master Fund 및 Robert S. Pitts Jr.가 기재되어 있으며, Pitts 씨가 해당 투자운용사의 지배 주체입니다. 투자운용사는 두 펀드가 보유한 주식에 대해 공동으로 의결권 및 처분권을 보유하고 있습니다. 성명에서는 보유 목적이 발행사의 지배권 변경 또는 영향력을 행사하기 위한 것이 아님을 인증합니다.

Steadfast Capital Management LP et des entités affiliées ont déclaré une détention bénéficiaire de 11 320 754 actions ordinaires de 180 Life Sciences Corp., soit 7,3 % de 154 032 084 actions en circulation. Le dépôt nomme le gestionnaire d'investissement (Investment Manager), American Steadfast, le Steadfast International Master Fund et Robert S. Pitts Jr. ; M. Pitts est le principal dirigeant contrôlant du gestionnaire. Le gestionnaire d'investissement détient des pouvoirs de vote et de disposition partagés sur les actions détenues par les deux fonds. La déclaration certifie que ces participations ne sont pas détenues dans le but de modifier ou d'influencer le contrôle de l'émetteur.

Steadfast Capital Management LP und verbundene Unternehmen meldeten wirtschaftliches Eigentum an 11.320.754 Stück Stammaktien von 180 Life Sciences Corp., entsprechend 7,3% von 154.032.084 ausstehenden Aktien. Die Einreichung nennt den Investment Manager, American Steadfast, den Steadfast International Master Fund und Robert S. Pitts Jr.; Herr Pitts ist der kontrollierende Hauptgesellschafter des Investment Managers. Der Investment Manager verfügt über geteilte Stimm- und Verfügungsbefugnisse bezüglich der von den beiden Fonds gehaltenen Aktien. Die Erklärung bestätigt, dass die Beteiligungen nicht gehalten werden, um die Kontrolle des Emittenten zu ändern oder zu beeinflussen.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



STEADFAST CAPITAL MANAGEMENT LP
Signature:/s/ Sheena Koshy
Name/Title:Sheena Koshy/Chief Operating Officer
Date:08/12/2025
American Steadfast, L.P.
Signature:/s/ Sheena Koshy
Name/Title:Sheena Koshy/Chief Operating Officer of Steadfast Capital Management LP, Attorney-in-Fact
Date:08/12/2025
Steadfast International Master Fund Ltd.
Signature:/s/ Sheena Koshy
Name/Title:Director
Date:08/12/2025
Robert S. Pitts, Jr.
Signature:/s/ Robert S. Pitts, Jr
Name/Title:Robert S. Pitts, Jr.
Date:08/12/2025
Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B

FAQ

Who filed the Schedule 13G for 180 Life Sciences Corp. (ATNFW)?

Steadfast Capital Management LP, American Steadfast L.P., Steadfast International Master Fund Ltd. and Robert S. Pitts Jr.

How many shares and what percentage did the Reporting Persons disclose for ATNFW?

11,320,754 shares, representing 7.3% of 154,032,084 shares outstanding

Does the Schedule 13G indicate the stake is intended to change control of 180 Life Sciences (ATNFW)?

No; Item 10 includes a certification that the securities were not acquired to change or influence control.

Which entities hold the disclosed shares for ATNFW and how is voting power described?

American Steadfast holds 4,109,434 shares and the Offshore Fund holds 7,211,320 shares; shared voting and dispositive power with the Investment Manager and Mr. Pitts is reported.

Who is identified as the controlling principal of the Investment Manager?

Robert S. Pitts Jr. is identified as the controlling principal of the Investment Manager.
180 Life Sciences Corp

NASDAQ:ATNFW

ATNFW Rankings

ATNFW Latest News

ATNFW Latest SEC Filings

ATNFW Stock Data

5.19M
Biotechnology
Pharmaceutical Preparations
Link
United States
PALO ALTO